The Aporia
2 articles about 2 events for “Prediction Market Boom” in Health.
“Earlier this summer, the company's peak share price amid the AI boom made it, in cash terms, the most valuable UK-based company in history.”
“Though Rader doesn't necessarily consider such predictions to be wrong, he pointed out that many prediction models are based on data from before the boom in GLP-1 drugs and might not take into account their potential effects.”